Testing for Ns5a Resistance in Order to Optimize Antiviral Therapy With Simeprevir And Sofosbuvir 12 Weeks Appears Cost-Effective in Non-Cirrhotic Genotype 1 Hepatitis C Virus Treatment Experienced Patients

Testing for Ns5a Resistance in Order to Optimize Antiviral Therapy With Simeprevir And Sofosbuvir 12 Weeks Appears Cost-Effective in Non-Cirrhotic Genotype 1 Hepatitis C Virus Treatment Experienced Patients

Saved in:
Bibliographic Details
Published in:Value in health Vol. 18; no. 7; p. A589
Main Authors: Westerhout, KY, Bouwmeester, W, Duchesne, I, Sbarigia, U, Pisini, M, Treur, M
Format: Journal Article
Language:English
Published: United States 01-11-2015
Subjects:
Internal Medicine
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:1098-3015
1524-4733
DOI:10.1016/j.jval.2015.09.1509